1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Demographics, clinical outcome measures, stroke risk factors, and acute infarct characteristics among those diagnosed with an acute ischemic stroke and those who were suspected of having an acute stroke but did not have an infarct (non-stroke)
Acute Stroke (n = 52) Nonstroke (n = 36) P Demographics Age (mean) (SD) (yr) 69.2 (17.4) 62.2 (17.7) .068 Women (No.) (%) 28 (54.0%) 19 (52.8%) .907 Black (No.) (%) 17 (32.7%) 13 (36.1%) .715 Clinical outcome measures Motricity Index (median) (IQR) 77 (44–92) NA – NIH Stroke Scale (median) (IQR) 4 (2–13) NA – Stroke risk factors Diabetes mellitus 14 (26.9%) 7 (19.4%) .394 Hypertension 40 (76.9%) 24 (66.7%) .309 Atrial fibrillation/flutter 13 (32.5%) 8 (22.2%) .595 Dyslipidemia 27 (51.9%) 17 (47.2%) .652 Cardiomyopathy 14 (26.9%) 7 (19.4%) .271 Smoking history 17 (32.7%) 8 (22.2%) .612 Infarct characteristics Median infarct volume (IQR) (mL) 1.1 (0.3–9.2) NA – Infarct overlap with corticospinal tract (No.) (%) 36 (69.2%) NA – Side of infarct, right (No.) (%) 31 (59.6%) NA – Median white matter hyperintensity volume (IQR) (mL) 11.7 (2.2–35.2) 10.1 (1.93–26.7) .143 Stroke subtype Cardioembolic 12 (23.1%) NA – Small artery disease 11 (21.2%) NA – Large atherosclerosis 13 (25.0%) NA – Cryptogenic 14 (26.9%) NA – Other 2 (3.8%) NA – IV-tPA cases 10 (19.2%) NA – Thrombectomy rate 5 (9.6%) NA –
Note:—NA indicates not applicable; IV-tPA, intravenous tissue-type plasminogen activator; NIH, National Institutes of Health.